NextTrip, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NextTrip, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $388.6K | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $641.0K | Apr 1, 2019 |
| FY2016 | Dec 31, 2016 | $966.4K | Mar 31, 2017 |
| FY2016 | Dec 31, 2015 | $1.23M | Mar 31, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $501.4K | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $458.8K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $382.8K | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $630.4K | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $1.65M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $807.5K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $402.4K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $388.6K | Mar 24, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $641.0K | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $966.4K | Apr 17, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $3.3K | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $61.2K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $27.9K | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $280.5K | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $1.09M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $215.5K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($171.9K) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $118.5K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $368.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $737.5K | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($10.12M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($7.33M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($5.03M) | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | ($8.69M) | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | ($7.38M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($5.20M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($6.32M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($5.57M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($4.42M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.20M) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($7.41M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($5.68M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($4.95M) | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | ($8.75M) | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | ($8.48M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($5.70M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($6.38M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($5.57M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($3.90M) | Apr 1, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $404.7K | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $417.7K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $126.3K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $648.0K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $493.4K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $302.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $120.6K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $330.6K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $219.1K | Mar 16, 2016 |
| FY2014 | Dec 31, 2013 | $14.3K | Mar 31, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($5.08M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($5.73M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($3.79M) | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | ($8.21M) | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | ($6.30M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($4.81M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($5.51M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($3.76M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($2.64M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.96M) | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 29, 2024 | $9.3K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $2.9K | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $164.6K | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $182.5K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $88.1K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $33.5K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $79.1K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $69.5K | Apr 1, 2019 |
| FY2015 | Dec 31, 2015 | $78.5K | Mar 16, 2016 |
| FY2015 | Dec 31, 2014 | $811.9K | Mar 16, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $9.94M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $5.09M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $5.88M | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $5.70M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $13.84M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $5.70M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.69M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.43M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $3.39M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.87M | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $2.57M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $1.96M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $5.40M | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $629.2K | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $981.2K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $536.8K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.04M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $695.8K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $382.9K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $892.3K | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $7.37M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $3.13M | May 29, 2025 |
| FY2025 | Feb 28, 2023 | $484.1K | May 29, 2025 |
| FY2022 | Dec 31, 2022 | $5.07M | Mar 30, 2023 |
| FY2024 | Feb 28, 2022 | ($11.78M) | Sep 4, 2024 |
| FY2022 | Dec 31, 2021 | $12.86M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $5.16M | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $652.2K | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.74M | Mar 24, 2021 |
| FY2019 | Dec 31, 2017 | $3.01M | Mar 24, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.17M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $1.17M | May 29, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($34.35M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($24.15M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($16.81M) | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | ($49.34M) | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | ($40.59M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($33.11M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($26.10M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($19.77M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($14.19M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($9.76M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.06M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $323.8K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $282.5K | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | $2.85M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $11.45M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.70M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $86.9K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.28M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.52M | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $398.4K | Apr 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | (2) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | (32) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | (70) | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | 0 | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | (2) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | (32) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | (70) | Sep 4, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 1.66M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 936,430 | May 29, 2025 |
| FY2025 | Oct 12, 2023 | 780,423 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 83,371 | Sep 4, 2024 |
| FY2022 | Dec 31, 2022 | 10.50M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | 10.50M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 6.00M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 1.40M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | 877,663 | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 4.98M | Apr 1, 2019 |